Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation
- PMID: 23645247
- DOI: 10.1038/clpt.2013.89
Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation
Similar articles
-
Academia-pharma partnerships for novel drug discovery: essential or nice to have?Expert Opin Drug Discov. 2017 Jun;12(6):537-540. doi: 10.1080/17460441.2017.1318124. Epub 2017 Apr 17. Expert Opin Drug Discov. 2017. PMID: 28394189 No abstract available.
-
Improving the efficacy of translational medicine by optimally integrating health care, academia and industry.Nat Med. 2011 Dec 6;17(12):1567-9. doi: 10.1038/nm.2583. Nat Med. 2011. PMID: 22146467 Free PMC article. No abstract available.
-
Europe's innovation hub finally KICs off.Nature. 2011 Feb 24;470(7335):450. doi: 10.1038/470450a. Nature. 2011. PMID: 21350459 No abstract available.
-
Open PHACTS: semantic interoperability for drug discovery.Drug Discov Today. 2012 Nov;17(21-22):1188-98. doi: 10.1016/j.drudis.2012.05.016. Epub 2012 Jun 7. Drug Discov Today. 2012. PMID: 22683805 Review.
-
Translational research and the evolving landscape for biomedical innovation.J Investig Med. 2012 Oct;60(7):995-8. doi: 10.2310/JIM.0b013e318268694f. J Investig Med. 2012. PMID: 22918200 Free PMC article. Review.
Cited by
-
Changing Trends in Computational Drug Repositioning.Pharmaceuticals (Basel). 2018 Jun 5;11(2):57. doi: 10.3390/ph11020057. Pharmaceuticals (Basel). 2018. PMID: 29874824 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources